Back to search

Prevention and treatment of diabetic nephropathy

Data up to Jan 2025

Published2005
Citations114
References23

Total Citations Per Year

Abstract

References (23)

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

1993 • 23,535 citations

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

1998 • 19,638 citations

Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization

2004 • 10,671 citations

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

1998 • 8,603 citations

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

2003 • 2,931 citations

Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction

2004 • 1,882 citations

Positionally Cloned Gene for a Novel Glomerular Protein—Nephrin—Is Mutated in Congenital Nephrotic Syndrome

1998 • 1,822 citations

Nephropathy in Diabetes

2004 • 1,040 citations

Preventing Microalbuminuria in Type 2 Diabetes

2004 • 1,000 citations

National Kidney Foundation K/DOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure

2001 • 999 citations

Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy

2004 • 729 citations

Nephrin Expression Is Reduced in Human Diabetic Nephropathy

2003 • 338 citations

Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension

2001 • 242 citations

Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition

2002 • 224 citations

Why is proteinuria an ominous biomarker of progressive kidney disease?

2004 • 166 citations

Clinical Pharmacokinetics and Pharmacodynamics of Repaglinide

2002 • 143 citations

The pharmacokinetics of pioglitazone in patients with impaired renal function

2003 • 141 citations

Management of drugs affecting blood glucose in diabetic patients with renal failure.

2000 • 132 citations

Pharmacokinetics of Rosiglitazone in Patients with Varying Degrees of Renal Insufficiency

2003 • 77 citations

Receptors for proteins modified by advanced glycation endproducts (AGE)—their functional role in atherosclerosis

1999 • 62 citations

Pharmacokinetics of Nateglinide in Renally Impaired Diabetic Patients

2003 • 34 citations

Suicide of the nephron

2001 • 26 citations

Oral hypoglycaemics. When not to use what.

2002 • 4 citations

Cited By (0)

Loading...
Prevention and treatment of diabetic nephropathy (2005) – Diabetes Research and Clinical Practice | Metascience Observatory Explorer